These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3186616)

  • 1. Lithium-induced morphological changes in the rat kidney at different levels of urine flow.
    Ottosen PD; Jacobsen NO; Christensen S
    Pharmacol Toxicol; 1988 Aug; 63(2):108-13. PubMed ID: 3186616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid mediators and MgATPase modulation causes changes in the cardiovascular effects of vasopressin in lithium carbonate-induced polyuric rats.
    Tyagi MG; Shanthi M; Keshavan V; Vikram GS
    Methods Find Exp Clin Pharmacol; 2004 May; 26(4):257-62. PubMed ID: 15319803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of lithium-induced polyuria in the rat.
    Carney SL; Ray C; Gillies AH
    Kidney Int; 1996 Aug; 50(2):377-83. PubMed ID: 8840263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of lithium polyuria].
    Liubimov BI; Iavorskiĭ AN; Gorianov OA; Rychko AV; Samoĭlov NN
    Farmakol Toksikol; 1977; 40(1):76-9. PubMed ID: 140064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and structural changes in the rat kidney by long-term lithium treatment.
    Christensen S; Hansen BB; Faarup P
    Ren Physiol; 1982; 5(2):95-104. PubMed ID: 7071412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
    de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria.
    Sugawara M; Hashimoto K; Ota Z
    Am J Physiol; 1988 Jun; 254(6 Pt 2):R863-9. PubMed ID: 2454589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria.
    Rao R; Zhang MZ; Zhao M; Cai H; Harris RC; Breyer MD; Hao CM
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F642-9. PubMed ID: 15585669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium induced polyuria and renal vasopressin receptor density.
    Hensen J; Haenelt M; Gross P
    Nephrol Dial Transplant; 1996 Apr; 11(4):622-7. PubMed ID: 8671849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and structural rat kidney changes caused by peroral or parenteral lithium treatment.
    Plenge P; Mellerup ET; Nørgaard T
    Acta Psychiatr Scand; 1981 Apr; 63(4):303-13. PubMed ID: 7315479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term lithium administration on renal structure and function in rats. A distinctive tubular lesion.
    Kling MA; Fox JG; Johnston SM; Tolkoff-Rubin NE; Rubin RH; Colvin RB
    Lab Invest; 1984 May; 50(5):526-35. PubMed ID: 6716969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium and the antidiuretic hormone.
    MacNeil S; Jennings G; Eastwood PR; Paschalis C; Jenner FA
    Br J Clin Pharmacol; 1976 Apr; 3(2):305-13. PubMed ID: 788747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early renal changes in lithium-treated normal and vasopressin-deficient rats.
    Jacobsen NO; Ottosen PD; Christensen S
    APMIS Suppl; 1988; 4():56-65. PubMed ID: 3224025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of lithium-induced polyuria in the rat.
    Christensen S
    Scand J Clin Lab Invest; 1980 Apr; 40(2):151-7. PubMed ID: 7256183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mechanism of lithium-induced diabetes insipidus in man and the rat.
    Forrest JN; Cohen AD; Torretti J; Himmelhoch JM; Epstein FH
    J Clin Invest; 1974 Apr; 53(4):1115-23. PubMed ID: 4360856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium-induced focal interstitial fibrosis in the rat kidney.
    Hestbech J; Olesen OV; Thomsen K
    Acta Pathol Microbiol Scand A; 1978 Mar; 86(2):195-7. PubMed ID: 696319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats.
    Christensen S; Kusano E; Yusufi AN; Murayama N; Dousa TP
    J Clin Invest; 1985 Jun; 75(6):1869-79. PubMed ID: 2989335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lithium and neuroleptics and combinations of the two on renal function and structure in rats.
    Christensen S; Kristensen AR; Faarup P
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):161-7. PubMed ID: 6121456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of lithium to rats by different routes.
    Olesen OV; Schou M; Thomsen K
    Neuropsychobiology; 1976; 2(2-3):134-8. PubMed ID: 1012448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of the lithium-induced diabetes-insipidus-like syndrome by amiloride in rats.
    Feuerstein G; Zilberman Y; Hemmendinger R; Lichtenberg D
    Neuropsychobiology; 1981; 7(2):67-73. PubMed ID: 7453952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.